USE OF HYOCHOLIC ACID (HCA) SPECIES IN PREPARATION OF MEDICAMENT FOR TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA

POST-OPERATIVE DELIRIUM SUPPRESSANT

QUERCETAGETIN ENRICHED MARIGOLD EXTRACTS, COMPOSITIONS, METHODS OF PREPARATION AND USE THEREOF

CHOLESTENOIC ACID (CA) AND A SULFATED DERIVATIVE THEREOF, 3[BETA]-SULFATE-5-CHOLESTENOIC ACID (CA3S), AS ENDOGENOUS EPIGENETIC REGULATORS

COMPOSITION FOR RELIEVING SKIN ITCHING OR SKIN SOOTHING

NOVEL THERAPEUTICS FOR PARASITIC INFECTION

SOLID DOSAGE FORM FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS

METHOD FOR INCREASING POLLINATION IN CROPS SUSCEPTIBLE TO POLLINATION OF INVERTEBRATES OF THE APIDEAE FAMILIES

POLYCYCLIC COMPOUNDS AND METHODS THEREOF

COMPOUND BASED ON OXIDATIVE STRESS AND ANTI-AMYLOID AGGREGATION MECHANISM, PREPARATION METHOD THEREFOR AND USE THEREOF

Treatment of Alcoholic Hepatitis

HUMAN AMINOSTEROL ENT-03 COMPOUNDS, RELATED COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USING THE SAME

COMPOUNDS FOR USE IN THE TREATMENT OF LIVER DISEASE

METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH PRIDOPIDINE

ANTI-CD123 IMMUNOCONJUGATES FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES

METABOLIC MODULATION OF INTRATUMORAL CHOLESTEROL WITH ENGINEERED BACTERIA FOR THE TREATMENT OF CANCERS

COMBINATION PRODUCT, SALT, AND USE THEREOF IN TREATING NEURODEGENERATIVE DISEASES OR DISORDERS

SYSTEMS AND METHODS FOR EPICARDIAL TISSUE DISTENSION SOLUTIONS

ULTRAVIOLET DEVICE

METHODS AND COMPOSITIONS FOR TREATING INTESTINAL DISORDER

Pharmaceutical Formulation and Dosing Regimen for the Treatment of Amyotrophic Lateral Sclerosis

METHOD FOR TREATING DAMAGE INDUCED BY SLEEP DEPRIVATION

METHODS FOR TREATING LIVER DISEASE

STEROLS AS NOVEL IMMUNOMODULATORY AGENTS AND THEIR USE AS VACCINE ADJUVANTS

PHARMACEUTICAL COMPOSITION CONTAINING B-LAPACHONE AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CHOLESTATIC LIVER DISEASE

RECONSTITUTED HIGH-DENSITY LIPOPROTEIN NANOPARTICLES COMPRISING CHOLESTEROL

ALPHA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF

TOPICAL TREATMENT OF WOUNDS WITH STATINS AND CHOLESTEROL FOR SCAR REDUCTION

SYSTEMS FOR GENERATING PERSONALIZED DIETARY SUPPLEMENTS

TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST

COMPOSITION FOR LOWERING BLOOD LIPIDS AND CHOLESTEROL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

GPX4 Inhibitors and Senolytic Compounds and Uses Thereof

COMPOUND OR SALT THEREOF, LIPID COMPOSITION, PHARMACEUTICAL COMPOSITION, AND DELIVERY CARRIER

COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

OXYSTEROLS AND METHODS OF USE THEREOF

METHODS FOR AMELIORATING COGNITIVE IMPAIRMENT USING BILE ACID DERIVATIVES

ORAL PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF OSTEOPOROSIS CONTAINING TERIPARATIDE AND METHOD FOR PREPARATION THEREOF

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

PHARMACEUTICAL COMBINATION COMPRISING A CHOLANE DERIVATIVE AND A STATIN OR URSODESOXYCHOLIC ACID

Lipid Compounds and Uses Thereof

COMPOSITION FOR PREVENTING AND/OR TREATING A PATHOLOGICAL DYSBIOSIS OF THE INTESTINAL MICROBIOTIA

METHOD FOR PREVENTING OR TREATING PROSTATIC HYPERPLASIA

CBD COMPOSITION

BATCH MANAGEMENT METHOD FOR IMPROVING FARROWING RATE OR NUMBER OF PIGLETS BORN ALIVE IN SWINE

TREATMENT FOR FIBROSIS AND INHIBITION OF FIBROSIS

IBAT INHIBITORS FOR THE TREATMENT OF LIVER DISEASES

COMPOUNDS, COMPOSITIONS AND METHODS THEREOF

METHODS OF MANAGING EOSINOPHILIC ESOPHAGITIS

GPX4 Inhibitors and Senolytic Compounds and Uses Thereof

NEUROACTIVE STEROID FOR THE TREATMENT OF ALZHEIMER'S DISEASE

DHCR24 INHIBITORY COMPOUNDS

COMPOSITIONS FOR PREVENTING TRANSITION FROM ACUTE TO CHRONIC PAIN

USES OF FARNESOID X RECEPTOR AGONISTS

CATIONIC STEROIDAL ANTIMICROBIAL SALTS

COMPOSITIONS FOR IMPROVING CELL VIABILITY AND METHODS OF USE THEREOF

DRUGS TARGETING INFLAMMATION FOR THE TREATMENT OF OSTEOARTHRITIS AND OTHER INFLAMMATORY DISEASES

PHARMACEUTICAL COMPOSITIONS OF NOR-UDCA

METHODS FOR MONITORING TREATMENT OF CHRONIC LIVER DISEASE

COMPOSITION FOR TREATMENT OF COVID-19 COMPRISING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT

IBAT INHIBITORS FOR THE TREATMENT OF LIVER DISEASES

OXYSTEROLS AND METHODS OF USE THEREOF

USE OF STEROID COMPOUND IN PREPARING DRUGS FOR PREVENTING AND/OR TREATING PRESBYOPIA

METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISTS AND BREAST CANCER

Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof And at Least One Cyclic Oligosaccharide

BIOLOGICALLY ACTIVE GANODERMA LUCIDUM COMPOUNDS AND SYNTHESIS OF ANTICANCER DERIVATIVES; ERGOSTEROL PEROXIDE PROBES FOR CELLULAR LOCALIZATION

Tripartite Modulators of Endosomal G Protein-Coupled Receptors

C25 R AND S ISOMERS OF AMINOSTEROLS AND METHODS OF MAKING AND USING THE SAME

COMPOSITIONS OF BILE ACIDS AND PHENYLBUTYRATE COMPOUNDS

Cardiovascular Health-Promoting Composition

PHARMACEUTICAL COMPOSITION COMPRISING CURCUMIN AND GINSENOSIDE, AND FORMULATION THEREOF

PHYTOECDYSONES AND/OR 20-HYDROXYECDYSONE DERIVATIVES IN COMBINATION WITH AN ACTIVE INGREDIENT FOR RESTORING SMN EXPRESSION, FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY

FORMS AND COMPOSITIONS OF SODIUM CHENODEOXYCHOLATE

7-KETOLITHOCHOLIC ACID FOR USE IN THE TREATMENT OF GUT DYSBIOSIS AND AS A PREBIOTIC

INACTIVATING BACTERIA WITH ELECTRIC PULSES AND ANTIBIOTICS

METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY

Optimizing Mifepristone Absorption

METABOLIC DISEASE THERAPEUTIC AGENT OR PREVENTIVE AGENT

Supplement for Cervical Health

HIGH PURITY NON-ANIMAL DERIVED TUDCA

COMBINATION THERAPIES AND METHODS OF USE THEREOF FOR TREATING CANCER

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING HERNIAS

LIQUID DEPOT FOR NON-INVASIVE SUSTAINED DELIVERY OF AGENTS TO THE EYE

PEPTIDE REGULATORS OF METABOLISM

Pharmaceutical Composition Of S-Ketamine Hydrochloride

Treatment of Pneumonia

PREPARATION OF NOVEL TRITERPENE ALCOHOL DERIVATIVES WITH ENHANCED BIOAVAILABILITY FOR CANCER, INFLAMMATION AND PAIN TREATMENT

COMBINATION THERAPY

STEROID COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

COMPOSITIONS FOR VITAMIN D PRODUCTION

CHANNEL MODULATORS

METHODS AND SYSTEMS FOR INDUCING APOPTOSIS OF ADIPOSE CELLS

COMPOSITION FOR TREATING CORONAVIRUS DISEASE 2019 (COVID-19) CONTAINING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND ANTIVIRAL AGENT AS ACTIVE INGREDIENTS

GEL COMPOSITION FOR PREVENTION OR TREATMENT OF ATOPIC DERMATITIS

COMPOSITION BASED ON PLANT EXTRACTS AND USE THEREOF FOR THE PREVENTION AND/OR TREATMENT OF CARBOHYDRATE AND LIPID DYSMETABOLISM

LIQUID DEPOT FOR NON-INVASIVE SUSTAINED DELIVERY OF AGENTS TO THE EYE

STEROL THERAPY

PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

TWO-PRONGED TREATMENT FOR NIEMANN PICK TYPE C DISEASE

CRYSTAL FORM OF HIGH-STABILITY NOR-URSODEOXYCHOLIC BERBERINE SALT, AND PREPARATION METHOD THEREFOR

COMPOSITION FOR PREVENTING OR TREATING PULMONARY FIBROSIS, COMPRISING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT

TREATING LIVER DISORDERS WITH AN SSAO INHIBITOR

COMBINATION FOR USE FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA, CARDIOVASCULAR DISEASE AND METABOLIC SYNDROME

NANOEMULSION ENDOWED WITH ANTISEPTIC EFFECT

Breath Actuated Inhaler

BIORESORBABLE CATIONIC STEROIDAL ANTIMICROBIAL COMPOUNDS WITH GLYCERIDE LINKAGES

MURICHOLIC ACIDS AND DERIVATIVES FOR CHOLESTASIS TREATMENT

USE OF GLUCOCORTICOID RECEPTOR MODULATORS TO POTENTIATE CHECKPOINT INHIBITORS

COMBINATION OF MUSCARINIC RECEPTOR POSITIVE MODULATORS AND NMDA POSITIVE ALLOSTERIC MODULATORS

METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS

25-HYDROXYCHOLESTEROL (25HC), CRYAB AGGREGATION INHIBITOR TO AMELIORIATE VASCULAR STIFFNESS

NEUROACTIVE STEROID FOR THE TREATMENT OF HUNTINGTON'S DISEASE

TREATMENT FOR PRIMARY BILIARY CHOLANGITIS

COMPOSITIONS AND METHODS OF CLOSTRIDIODIDES DIFFICILE TREATMENT, DECOLONIZATION, AND PREVENTION

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VARIOUS DISEASES

HERBAL BIOACTIVES BASED IMMUNOSTIMULANT FORMULATION FOR POULTRY BIRDS & CATTLE AND PREPARATION THEREOF

COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE

COMPOSITION

USES OF COMPOSITIONS COMPRISING A PREBIOTIC COMPONENT

TRANSPORE DELIVERY OF STEROIDS AND LARGE MOLECULES

METHODS OF TARGETING RNF213 SIGNALING PATHWAY FOR TREATING DISEASES

COMBINATION OF A BILE ACID AND A PHENYL BUTYRATE COMPOUND FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

PREPARATION AND USES OF OBETICHOLIC ACID

GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS

METHODS FOR EXTENDING LIFESPAN AND/OR DELAYING AGING

LIPID EMULSIONS FOR PARENTERAL NUTRITION

PHARMACEUTICAL COMPOSITION HAVING ANTI-CANCER IMMUNOSTIMULATING EFFECT AND/OR IMMUNE CHECKPOINT INHIBITION POTENTIATING EFFECT

GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS

COMPOSITION CONTAINING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL INFECTIOUS DISEASES

TREATMENT OF SEPSIS AND SEPTIC SHOCK

OPHTHALMIC FORMULATION FOR PREVENTING AND/OR TREATING CATARACTS BY EYE DROP ADMINISTRATION

25-Hydroxy-Cholest-5-En-3-Sulfate Choline and Methods for Preparing, and Uses of, Same

METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS

DEUTERATED POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF

PHYTOENE-CONTAINING OLEORESIN AND COMPOSITION

GPX4 Inhibitors and Senolytic Compounds and Uses Thereof

FARNESOID X RECEPTOR MODULATORS

PHARMACEUTICAL COMPOSITION CONTAINING 27-HYDROXYCHOLESTEROL FOR PREVENTING OR TREATING MYELOID LEUKEMIA

Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage Disorders

BOTANICAL EXTRACTS AND COMPOUNDS FROM SCHINUS PLANTS AND METHODS OF USE

Compositions and Methods for the Repair of Myelin

THE USE OF THE ACTIVE COMPOUND IN THE PREVENTION OR TREATMENT OF OVARIAN DYSFUNCTION DISEASES

COMBINATION THERAPY FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

COMPOSITIONS AND USE THEREOF FOR RE-ESTABLISHING INTESTINAL PERMEABILITY AND/OR PREVENTING OR COMBATTING MULTIFACTORIAL DISEASES

COMPOSITIONS OF POLYLYSINE CONJUGATES AND OF MICELLES AND/OR COPOLYMERS OF POLYLYSINE

METHODS OF ACTIVATING MICROGLIAL CELLS

USE OF TERPENOIDS IN THE TREATMENT OF MASTOCYTOMA

APPLICATION OF STEROID COMPOUND IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING EYE FLOATERS

METHODS FOR EVALUATING AND IMPROVING COGNITIVE FUNCTION

POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

COMPOSITIONS AND METHODS FOR IMPROVED TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY

METHODS FOR THE TREATMENT OF OCULAR ROSACEA

CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATORS AND CYP3A INHIBITORS

APPLICATION OF B-ECDYSTERONE IN PREPARATION OF MEDICINE FOR URIC ACID-LOWERING AND HYPERURICEMIC KIDNEY INJURY

DRUG CARRIER COMPOSITION AND HYPOGLYCEMIC DRUG

Bile Acids and Use in Disease Treatment

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING MUCOSAL TISSUE DAMAGE OR DISEASE

IMMUNE MEMORY INDUCTION BY PLATINUM BASED COMPOUNDS

PULSE PROTEIN-BASED COMPOSITION FOR ACTIVATING THE SYNTHESIS OF FGF19

OPHTHALMIC COMPOSITION FOR THE TREATMENT OF VISUAL DISORDERS

MOLECULAR ASSOCIATION OF BILE ACID OR BILE SALT AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR LOCALLY REDUCING FAT

COMBINATION THERAPIES COMPRISING OXYGEN-CONTAINING STRUCTURALLY ENHANCED FATTY ACIDS FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS

COMBINATION TREATMENT OF LIVER DISORDERS

Fermented Uni-sourced Nanoemulsion of Nigella sativa or Cannabis sativa For Use in Medical, Cosmetic, and Recreational Indications with a Method of Its Production and Use

BOTANICAL EXTRACTS AND COMPOUNDS FROM SCHINUS PLANTS AND METHODS OF USE

Topical Composition and Carrier for Administration of Pharmaceutically or Cosmetically Active Ingredients

Treatment for Skeletal Diseases Caused by Intracellular Protein Trafficking Defects

METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING NEURODEGENERATIVE DISEASES

TOPICAL TREATMENT OF WOUNDS WITH STATINS AND CHOLESTEROL FOR SCAR REDUCTION

COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY

AMORPHOUS NANO-MOLECULAR AGGREGATE COMPOSED OF ORGANIC MATERIAL, INORGANIC MATERIAL, OR SALT THEREOF, AND METHOD FOR PREPARING SAME

NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE

TREATMENT FOR AUTOIMMUNE DISEASES

LIQUID DEPOT FOR NON-INVASIVE SUSTAINED DELIVERY OF AGENTS TO THE EYE

Oxysterols and methods of use thereof

COMPOSITIONS AND METHODS FOR TREATING BRAIN-GUT DISORDERS

RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS

COMPOUNDS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE

COMPOSITION COMPRISING INOTODIOL FOR PREVENTION OR TREATMENT OF MUSCULAR DISEASE

COMBINATION THERAPY FOR NEURODEGENERATIVE DISEASES

USE OF OVATODIOLIDE IN THE TREATMENT OR PREVENTION OF FIBROTIC CONDITIONS

NEUROACTIVE STEROID FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT ASSOCIATED WITH PARKINSON'S DISEASE

COMPOSITIONS AND METHODS FOR IMPROVING SKIN BARRIER

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS

EDTA AND EGTA FOR USE IN PRESERVING THE INTEGRITY OF THERAPEUTIC COMPOUNDS

TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS

STRONG POTENTIATION OF TLR3 AGONISTS EFFECTS USING FXR AGONISTS AS A COMBINED TREATMENT

MOUSE MYOPIA-INDUCED MODEL AND ENDOPLASMIC RETICULUM STRESS SUPPRESSANT FOR PREVENTING AND SUPPRESSING MYOPIA

HIGH STEROL-CONTAINING LIPID NANOPARTICLES

PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CARDIOVASCULAR DISEASES

COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM

Pharmaceutical composition for use in the therapeutic treatment of cancer and complications of cancer

BIOEFFECTIVE KRILL OIL COMPOSITIONS

Composition for inhibiting intestinal permeability, treating leaky gut related diseases and/or preventing leaky gut related diseases

COMPOSITE DRUG PARTICLES AND USES THEREOF

METHODS OF TREATING PAIN AND DEPRESSION

ORALLY ADMINISTRABLE FORMULATION

USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS IN COMBINATION WITH GLUCOCORTICOIDS TO TREAT ADRENAL INSUFFICIENCY

ANTIOXIDANT COMPOSITIONS AND METHODS OF USE

THIOPHENE DERIVATIVES FOR USE IN TREATING PORTAL INFLAMMATION AND FIBROSIS

WATER-BASED PHARMACEUTICAL COMPOSITION CONTAINING URSODEOXYCHOLIC ACID OR SALT THEREOF

Methods and compositions related to glucocorticoid receptor antagonists and breast cancer

METHOD AND COMPOSITION FOR REVERSING AND/OR INHIBITING ATHEROSCLEROSIS

INHIBITORS OF CYTOCHROME P450 FAMILY 7 SUBFAMILY B MEMBER 1 (CYP7B1) FOR USE IN MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS

TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST

METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS

COMPOSITIONS AND METHODS OF TREATING CONDITIONS

IONIC LIQUID FORMULATIONS FOR TREATING DIABETES

TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS

LIPOPEPTIDES FOR USE IN TREATING LIVER DISEASES AND CARDIOVASCULAR DISEASES

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN CONDITIONS

CORTICOSTEROID COMPOSITIONS

METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT AND SKIN TIGHTENING

SYNERGISTIC EFFECT OF A FXR AGONIST AND IFN FOR THE TREATMENT OF HBV INFECTION

Methods and Compositions for Treating Amyotrophic Lateral Sclerosis

Inactivating bacteria with electric pulses and antibiotics

ARTOCARPUS HETEROPHYLLUS COMPOSITION AND METHOD OF PROMOTING URINARY TRACT HEALTH

DRUG COCKTAIL FOR TREATMENT OF PARKINSON'S DISEASE, LEWY BODY DISEASE AND MULTIPLE SYSTEM ATROPHY

Cholesterol reducing compositions and methods of use thereof

METHODS FOR TREATMENT OF CANCER AND PHAGOCYTOSIS-DEFICIENCY RELATED DISEASES

ORAL FORMULATION OF BIOLOGICALLY ACTIVE MATERIAL CONJUGATE HAVING BIOTIN MOIETY, FATTY ACID MOIETY, OR COMBINATION THEREOF COUPLED THERETO

COMBINATION TREATMENT OF LIVER DISORDERS

Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

COMPOSITIONS AND METHODS FOR TREATING ECZEMA

CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES

LIPID-LIKE NANOCOMPLEXES AND USES THEREOF

CANNABINOID ENCAPSULATION TECHNOLOGY

COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS

URSODEOXYCHOLIC ACID DERIVATIVES FOR THE TREATMENT OF POLYCYSTIC DISEASES

METHODS FOR TREATING LUNG INFECTIONS AND INFLAMMATION

USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING INFLAMMATORY CONDITIONS

COMPOSITION FOR PROMOTING HAIR GROWTH AND/OR INHIBITING HAIR LOSS

PARENTERAL NUTRITION FORMULATION AND METHODS OF PREPARATION THEREOF

Use of Antcin H and Its Derivatives for Treating Central Nervous System Diseases

METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS

Methods and compositions for treating amyotrophic lateral sclerosis

PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES

Spirolactone compounds

Exosomal compositions and methods for the treatment of disease

Oxysterols and methods of use thereof

COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF VIRUS INFECTIONS

PREPARATION AND USES OF OBETICHOLIC ACID

COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR REGROWTH

COMPOUND FOR PREVENTING AND TREATING LIVER DISEASES AND PHARMACEUTICAL USE THEREOF

USES OF OXYGENATED CHOLESTEROL SULFATES (OCS)

Biomarkers in Primary Biliary Cholangitis

High sterol-containing lipid nanoparticles

Cardiovascular Health-Promoting Composition

TRANSPORE DELIVERY OF STEROIDS AND LARGE MOLECULES

PULMONARY FUNCTION TREATMENT

INOTODIOL AS AGONIST OF LIVER X RECEPTORS, AND USE THEREOF

USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AUTOIMMUNE CONDITIONS

USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AT LEAST ONE OF INSULIN RESISTANCE, DIABETES, AND PREDIABETES

Compound TSYI-ZAC for inhibiting dengue virus infection and medicinal use thereof

Methods and compositions for the treatment of steatosis-associated disorders

Methods and Compositions for the Treatment of Steatosis-Associated Disorders

OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT

METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS

PHARMACEUTICAL COMBINATION COMPRISING GLYCOLIC ACID AND L-ALANINE

COMPOSITION COMPRISING CANNABINOIDS, TERPENES, AND FLAVONOIDS FOR TREATING DEPRESSION

FOOD SUPPLEMENT FOR ALZHEIMER

Treatment for primary biliary cholangitis

METHOD FOR REGULATING EXPRESSION LEVEL OF MUSASHI1 IN CELLS

EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE

HISTONE-ACETYLATION-MODULATING AGENTS FOR THE TREATMENT AND PREVENTION OF ORGAN INJURY

Pharmaceutical Composition Of S-Ketamine Hydrochloride

FARNESOID X RECEPTOR MODULATORS

USE OF OXYGENATED CHOLESTEROL SULFATES FOR CANCERS AND NON-CANCEROUS TRANSFORMATIONS RELATED TO EPSTEIN-BARR VIRUS

COMPOSITIONS FOR SUPPLEMENTING PRODUCTS WITH THERAPEUTIC AGENTS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TREATMENT OF SOLID TUMORS

COMPOSITION FOR PROMOTING NORMAL URINARY FUNCTION

USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING NEUROLOGICAL CONDITIONS, NEURODEGENERATIVE DISEASES, AND ADDICTION

NEUROACTIVE COMPOUNDS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR DIAGNOSING, PREVENTING, AND TREATING AMYOTROPHIC LATERAL SCLEROSIS IN PATIENTS WITH HYPOFUNCTIONAL ANTI-TRYPSIN ACTIVITY

LIPOSOMAL COMPOSITION FOR USE IN A METHOD OF TREATING PARKINSON'S DISEASE

Compositions of bile acids and phenylbutyrate compounds

Methods of Treating Residual Lesions of Vascular Anomalies

ALLEVIATION OF LIVER INJURY BY ACTIVATING THE SIGNALING PATHWAY MEDIATED BY FARNESOID X RECEPTOR

USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

USE OF NAD+ PRECURSORS, STING INHIBITORS, AND FXR AGONISTS FOR INHIBITING SARS-COV-2 (COVID-19)-INDUCED CYTOKINE RELEASE

Treatment for primary biliary cholangitis

USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS

TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)

TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)

TREATING LIVER DISORDERS WITH AN SSAO INHIBITOR

METHODS FOR INDUCING BILE ACID SULFOTRANSFERASE SULT2A FOR TREATING METABOLIC DISORDERS

CHANNEL MODULATORS

METHODS OF USING BILE ACIDS TO TREAT VIRAL INFECTIONS

MULTI-DRUG FORMULATIONS FOR SUBCUTANEOUS BIODEGRADABLE RESERVOIR DEVICE

CRYSTALLINE FORMS OF SQUALAMINE

PHYTOECDYSONES FOR USE IN THE PREVENTION OF MUSCLE STRENGTH LOSS DURING IMMOBILISATION

ONAPRISTONE EXTENDED-RELEASE COMPOSITIONS AND METHODS

Use of a nitrogen-containing bisphosphonate in combination with a glucocorticoid in preventing or treating viral pneumonia

COMPOUNDS AND METHODS FOR TREATMENT OF PRIMARY BILIARY CHOLANGITIS

COMPOSITION AND METHOD FOR TREATMENT OF DIABETES

TREATMENT OF INFECTIOUS DISEASES